New research from the Mayo Clinic indicates a protein known for its role in Parkinson's disease could help explain why women comprise a significant majority of Alzheimer's cases. In a study of 415 individuals, researchers found that in women with abnormal alpha-synuclein and Alzheimer's markers, brain changes related to tau protein buildup occurred up to 20 times faster than in men.
This accelerated tau accumulation in women with misfolded alpha-synuclein suggests a potential biological difference influencing Alzheimer's progression. Scientists theorize that alpha-synuclein might act as an accelerant for tau buildup, a hallmark of Alzheimer's-damaged brains. These findings could lead to more targeted clinical trials and treatments, acknowledging that Alzheimer's may not affect everyone uniformly.
Researchers controlled for factors like age and genetic risk, isolating the connection between these proteins. While the exact biological mechanisms are still under investigation, hypotheses include the impact of estrogen decline in women post-menopause or malfunctioning alpha-synuclein acting as an amplifier for inflammation and tau clumping. This research opens new avenues for understanding sex-specific differences in dementia and could aid in differentiating between overlapping neurological conditions.